Bayer Aktiengesellschaft

Thomas Kr Amer

Johannes-Peter Stasch

Andreas Knorr

Peter Fey

Stanislav Kazda

Stefan Wohlfeil

Martin Beuck

Rudolf H Hanko

Ulrich E M Uller

Matthias M uller-Gliemann

J Urgen Dressel

Walter H Ubsch

Siegfried Zaiss

Hilmar Bischoff

Dirk Denzer

Claudia Hirth-Dietrich

Ozkan Yalkinoglu

Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives can be prepared by reacting sulphonylbenzyl-substituted aldehydes with appropriate CH-acidic compounds and then dehydrating. The sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives can be used in medicaments, in particular for the treatment of high blood pressure and atherosclerosis.

Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives

Substituted biphenylpyridones can be prepared by alkylating pyridones on the nitrogen. The substituted biphenylpyridones are suitable as active substances in medicaments, in particular in hypotensive and anti-atherosclerotic medicaments.

Substituted biphenylpyridones

The substituted monopyridyl and bipyridyl derivatives are prepared by reacting substituted pyridine halides with phenylboronic acids. They are suitable for use as active compounds in medicaments for treating arterial hypertension and atherosclerosis.

Substituted monopyridylmethyl derivatives

Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives are prepared by reacting phenylacetic acids with glycinamides. The compounds can be used as active compounds in medicaments.

Phenylglycinamides of heterocyclically substitued phenylacetic acid

Growing community of inventors

Wuppertal, Germany

Thomas Kr Amer